Comparing the Cost Effectiveness of Risperidone and Olanzapine in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

A. Laupacis, David Feeny, Allan S. Detsky et al. · PubMed · 1992 · 1.6K citations

Pharmacy, Pharmacoeconomics, Health Economics +16

Net Health Benefits

Aaron A. Stinnett, John Mullahy · Medical Decision Making · 1998 · 1.1K citations

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +11

Is Technological Change In Medicine Worth It?

David Cutler, Mark McClellan · Health Affairs · 2001 · 884 citations

Social Sciences, Health Care Management, Health Policy +17

Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis

Jeffrey S. Hoch, Andrew Briggs, Andrew R. Willan · Health Economics · 2002 · 547 citations

Pharmacy, Economics, Pharmacoeconomics +12

Carrier Screening for Cystic Fibrosis

David A. Asch, John C. Hershey, Michael L. DeKay et al. · Medical Decision Making · 1998 · 375 citations

Medicine, Pharmacoeconomics, Preventive Medicine +17